Miena Amiri
6 Nov 2023
Through Creative Destruction Lab (CDL), AVAYL receives mentorship from select entrepreneurs and angel investors in the field of AI and life science
We are pleased to announce that AVAYL has been selected for the Creative Destruction Lab (CDL) Oxford 2023/2024 cohort, particularly within the AI track. This selection represents a strategic milestone for us as we aim to further develop our AI capabilities and align them closely with the needs of Medical Affairs teams in the pharmaceutical and life sciences industries.
Why CDL Oxford?
CDL Oxford is not just another accelerator; it’s a global hub for innovation. The program pairs innovative companies with a network of experienced mentors, including former pharmaceutical executives and AI industry leaders. For AVAYL, this means direct access to insights from individuals who have scaled businesses and navigated the complexities of the pharma and AI sectors.
Over the nine-month program, we will engage in rigorous objective-setting sessions with these mentors, allowing us to fine-tune our AI tools to better serve the standards of Medical Affairs.
How CDL Benefits AVAYL and Our Customers
The CDL experience will allow us to improve our AI-driven tools, ensuring they are not only innovative but also compliant and user-friendly for Medical Affairs teams. This process will involve refining our workflows and adapting our technology to better meet the specific requirements of our users, something that we anticipate will significantly increase the value we deliver to our customers.
As we move forward, the insights and connections gained from CDL Oxford will be important in helping AVAYL scale and bring our AI innovations to a broader audience. We’re excited about the journey ahead and look forward to sharing our progress with you.